Key Research on TNBC: Top 5 Picks From SABCS
Experts weighed in on the most significant research on triple-negative breast cancer from this year's San Antonio Breast Cancer Symposium.
Stay updated with breaking news from Iological Marker. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Experts weighed in on the most significant research on triple-negative breast cancer from this year's San Antonio Breast Cancer Symposium.
Adult survivors of pediatric Hodgkin lymphoma have accelerated epigenetic aging, and many have evidence of neurocognitive decline on standardized testing.
The top 3 things you should know to start your day.
Despite an extensive body of supportive evidence and recommendations from major cancer societies, many patients with cancer still do not undergo genomic testing or receive appropriate targeted therapy.
The Elecsys beta-amyloid (1-42) CSF II and Elecsys phospho-tau (181P) CSF assays are for use in adults aged 55 and older who are being evaluated for cognitive difficulties.